Prevention of EAE by PEGylated Antigenic Peptide
J. Pfeil, M. Simonetti, U. Lauer, B. von Thulen, P. Durek, C. Poulsen, J. Pawlowska, M. Kroger, R. Krahmer, F. Leenders, U. Hoffmann, A. Hamann
This study shows that PEGylated antigenic peptides can prevent EAE in mice by inducing regulatory T cells, but are ineffective when administered during peak disease.
bioRxiv · Sep 8, 2020Immunology